LIFE-B:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund UnHedged Units (CAD)

ETF | Others |

Last Closing

CAD 25.3

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict
Created with Highstock 5.0.6

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
LIFE-B:CA XIU:CA
  • XIU:CA
Relative Returns (From:    To: 2025-03-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

-1.64 (-4.84%)

CAD 6.78B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 6.30B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.39 (-1.38%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

-0.19 (-0.78%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-1.70 (-4.76%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.44 (+0.95%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.75 (-2.65%)

CAD 3.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 3.55B
PSLV-U:CA Sprott Physical Silver Trust

-0.71 (-6.12%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.12 (-0.52%)

CAD 2.78B

ETFs Containing LIFE-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.72% 88% B+ 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.72% 89% A- 79% B-
Trailing 12 Months  
Capital Gain -0.78% 17% F 24% F
Dividend Return 5.02% 89% A- 84% B
Total Return 4.24% 34% F 32% F
Trailing 5 Years  
Capital Gain 19.28% 34% F 35% F
Dividend Return 38.33% 87% B+ 78% C+
Total Return 57.61% 41% F 41% F
Average Annual (5 Year Horizon)  
Capital Gain 2.26% 42% F 41% F
Dividend Return 3.10% 44% F 36% F
Total Return 0.85% 78% C+ 35% F
Risk Return Profile  
Volatility (Standard Deviation) 5.99% 76% C+ 88% B+
Risk Adjusted Return 51.86% 57% F 61% D-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.